Skip to main content

Advertisement

SpringerLink
Log in

Lung cancer risk in north Indian population: role of genetic polymorphisms and smoking

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Lung cancer (LC) is the leading cause of cancer-related mortality in developing as well as developed countries. Life style choices, particularly tobacco smoking, have been implicated as the main cause in the development of the LC. Despite the fact that majority cases of the LC occur among smokers, only 1–15% of smokers develop LC. In the present study, we have explored the role of genetic polymorphism, smoking habit and their association to LC in a cohort of north Indian population. The polymorphic genes explored were CYP1A1, GSTM1, GSTP1 and GSTT1 using techniques of Polymerase chain reaction (PCR), Restriction Fragment Length Polymorphism (RFLP), Real Time PCR (RT PCR), and gene sequencing. Genetic polymorphism was analysed in 253 normal participants (control) and 93 LC patients originating from Lucknow, India. Data were compared using odds ratio and Fisher Exact Test. We found that smoking increases the susceptibility to LC threefold (OR = 2.9; 95% CI: 0.9–2.8). The most significant risk for LC (OR = 3.2; 95% CI: 0.7–3.8) was found in the association of the homozygous variant of CYP1A1 gene at A2455G base change at Exon 7 (Val/Val) genotype. There was a marginally significant association between LC and GSTT1 null genotype (OR = 1.3; 95% CI: 1.0–1.7) while no significant risk association was found between GSTP1 polymorphism and LC. The present study demonstrates that the presence of null genotype of GSTM1/GSTT1 taken together with CYP1A1 (Val/Val) genotype increases the susceptibility to LC eightfold in comparison to CYP1A1 (Ile/Ile) and GSTM1/ GSTT1 genotype.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Vineis P (2002) The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Toxicology 181:457–462. doi:10.1016/S0300-483X(02)00450-X

    Article  PubMed  Google Scholar 

  2. Gonzalez FJ, Gelboin HV (1994) Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab Rev 26:165–183. doi:10.3109/03602539409029789

    Article  PubMed  CAS  Google Scholar 

  3. Carlsten C, Sagoo GS, Frodsham AJ, Burke W, Higgins JP (2008) Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol 167:759–774. doi:10.1093/aje/kwm383

    Article  PubMed  CAS  Google Scholar 

  4. Yang M, Choi Y, Hwangbo B, Lee JS (2007) Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer 57:135–142. doi:10.1016/j.lungcan.2007.03.005

    Article  PubMed  Google Scholar 

  5. Hayashi S, Watanabe J, Nakachi K, Kawajiri K (1991) Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem 110:407–411

    PubMed  CAS  Google Scholar 

  6. Pearson WR, Vorachek WR, Xu SJ, Berger R, Hart J, Vannais D, Patterson D (1993) Identification of class-mu glutathione transferase genes GSTM1–GSTM5 on human chromosome 1p13. Am J Hum Genet 53:220–233

    PubMed  CAS  Google Scholar 

  7. Landi S (2000) Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 463:247–283. doi:10.1016/S1383-5742(00)00050-8

    Article  PubMed  CAS  Google Scholar 

  8. Kano T, Sakai M, Muramatsu M (1987) Structure and expression of a human class pi glutathione S-transferase messenger RNA. Cancer Res 475:5626–5630

    Google Scholar 

  9. Morrow CS, Cowan KH, Goldsmith ME (1989) Structure of the human genomic glutathione S-transferase-pi gene. Gene 75:3–11. doi:10.1016/0378-1119(89)90377-6

    Article  PubMed  CAS  Google Scholar 

  10. Ali-Osman F, Akande O, Antoun G, Mao J, Buolamwini J (1997) Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. J Biol Chem 272:10004–10012. doi:10.1074/jbc.272.15.10004

    Article  PubMed  CAS  Google Scholar 

  11. Board PG, Webb GC, Coggan M (1989) Isolation of a cDNAclone and localization of the human glutathione S-transferase 3 genes to chromosome bands 11q13 and 12q13–14. Ann Hum Genet 53:205–213. doi:10.1111/j.1469-1809.1989.tb01786.x

    Article  PubMed  CAS  Google Scholar 

  12. Miller YE, Fain P (2003) Genetic susceptibility to lung cancer. Semin Respir Crit Care Med 24:197–204. doi:10.1055/s-2003-39018

    Article  PubMed  Google Scholar 

  13. Hung RJ, Boffetta P, Brockmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Garte S, Haugen A, Hirvonen A, Anttila S, Kalina I, Le Marchand L, London SJ, Rannug A, Romkes M, Salagovic J, Schoket B, Gaspari L, Taioli E (2003) CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis 24:875–882. doi:10.1093/carcin/bgg026

    Article  PubMed  CAS  Google Scholar 

  14. Shi X, Zhou S, Wang Z, Zhou Z, Wang Z (2008) CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. Lung Cancer 59:155–163. doi:10.1016/j.lungcan.2007.08.004

    Article  PubMed  Google Scholar 

  15. Shah PP, Singh AP, Singh M, Mathur N, Pant MC, Mishra BN, Parmar D (2008) Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. Mutat Res 639:1–10. doi:10.1016/j.mrfmmm.2007.10.006

    PubMed  CAS  Google Scholar 

  16. Cascorbi I, Brockmoller J, Roots I (1996) A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res 56:4965–4969

    PubMed  CAS  Google Scholar 

  17. Taioli E, Crofts F, Trachman J, Demopoulos R, Toniolo P, Garte SJ (1995) A specific African–American CYP1A1 polymorphism is associated with adenocarcinoma of the lung. Cancer Res 55:472–473

    PubMed  CAS  Google Scholar 

  18. Alexandrie AK, Nyberg F, Warholm M, Rannug A (2004) Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population. Cancer Epidemiol Biomarkers Prev 13:908–914

    PubMed  CAS  Google Scholar 

  19. Ng DP, Tan KW, Zhao B, Seow A (2005) CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women: influence of 15 environmental tobacco smoke exposure and GSTM1/T1 genetic variation. Cancer Causes Control 16:399–405. doi:10.1007/s10552-004-5476-0

    Article  PubMed  Google Scholar 

  20. Vineis P, Veglia F, Anttila S, Benhamou S, Clapper ML, Dolzan V, Ryberg D, Taioli E (2004) CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: a pooled analysis of gene–gene interactions. Biomarkers 9:298–305. doi:10.1080/13547500400011070

    Article  PubMed  CAS  Google Scholar 

  21. Sobti RC, Sharma S, Joshi A, Jindal SK, Janmeja A (2004) Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population. Mol Cell Biochem 26:1–9. doi:10.1023/B:MCBI.0000049127.33458.87

    Article  Google Scholar 

  22. Oyama T, Mitsudomi T, Kawamoto T, Osaki T, Kodama Y, Yasumoto K (1995) Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese. Int Arch Occup Environ Health 67:253–256. doi:10.1007/BF00409407

    Article  PubMed  CAS  Google Scholar 

  23. Basham VM, Pharoah PDP, Healey CS, Luben RN, Day E, Easton DF, Ponder BAJ, Dunning AM (2001) Polymorphism in CYP1A1 and smoking: no association with breast cancer risk. Carcinogenesis 22:1797–1800. doi:10.1093/carcin/22.11.1797

    Article  PubMed  CAS  Google Scholar 

  24. Abdel-Rehman SZ, El-Zein RA, Anwar WA, Au WW (1996) A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 gene in population studies. Cancer Lett 107:229–233. doi:10.1016/0304-3835(96)04832-X

    Article  Google Scholar 

  25. Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR (1997) Identification of genetic polymorphism at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostrate cancer. Carcinogenesis 18:641–644. doi:10.1093/carcin/18.4.641

    Article  PubMed  CAS  Google Scholar 

  26. Garte S, Gaspari L, Alexandrie AK, Ambrosome C, Autrup H, Taioli E (2001) Metabolic gene polymorphism frequencies in control population. Cancer Epidemiol Biomarkers Prev 10:1239–1248

    PubMed  CAS  Google Scholar 

  27. Abdel-Rahman SZ, Anwar WA, Abdel-Aal WE, Mostafa HM, Au WW (1998) GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect Prev 22:129–138. doi:10.1046/j.1525-1500.1998.00934.x

    Article  PubMed  CAS  Google Scholar 

  28. Ghosh P, Basu A, Mahata J, Basu S, Sengupta M, Das JK, Mukherjee A, Sarkar AK, Mondal L, Ray K, Giri AK (2006) Cytogenetic damage and genetic variants in the individuals susceptible to arsenic-induced cancer through drinking water. Int J Cancer 118:2470–2480. doi:10.1002/ijc.21640

    Article  PubMed  CAS  Google Scholar 

  29. Vettriselvi V, Vijayalakshmi K, Paul SF, Venkatachalam P (2006) Genetic variation of GSTM1, GSTT1 and GSTP1 genes in a South Indian population. Asian Pac J Cancer Prev 7:325–328

    Google Scholar 

  30. Jain M, Kumar S, Rastogi N, Lal P, Ghoshal UC, Mittal B (2006) GSTT1, GSTM1, and GSTP1 genetic polymorphisms and interaction with tobacco, alcohol and occupational exposure in esophageal cancer patients from North India. Cancer Lett 24:60–67. doi:10.1016/j.canlet.2005.10.034

    Article  Google Scholar 

  31. Mishra DK, Kumar A, Srivastava DS, Mittal RD (2004) Allelic variation of GSTT1, GSTM1 & GSTP1 genes in North Indian population. Asian Pac J Cancer Prev 5:362–365

    PubMed  Google Scholar 

  32. Naveen AT, Adithan C, Padmaja N, Shashindran CH, Abraham BK, Satyanarayanamoorthy K, Anitha P, Gerard N, Krishnamoorthy R (2004) Glutathione S-transferase M1 and T1 null genotype distribution in South Indians. Eur J Clin Pharmacol 60:403–406. doi:10.1007/s00228-004-0779-3

    Article  PubMed  CAS  Google Scholar 

  33. Benhamou S, Lee WJ, Alexandrie AK, Bofetta P, Bouchardy C, Butkiewicz D et al (2002) Meta-and pooled analyses of the effect of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 23:1334–1350. doi:10.1093/carcin/23.8.1343

    Article  Google Scholar 

  34. To-Figueras J, Gene M, Gomez-Catalan J, Galan MC, Fuentes M, Ramon JM et al (1997) Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms and lung cancer risk among Northwestern Mediterraneans. Carcinogenesis 18:1529–1533. doi:10.1093/carcin/18.8.1529

    Article  PubMed  CAS  Google Scholar 

  35. Lewis SJ, Cherry NM, Niven RML, Barber PV, Povey AC (2002) GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk. Cancer Lett 180:165–171. doi:10.1016/S0304-3835(02)00028-9

    Article  PubMed  CAS  Google Scholar 

  36. Stucker I, Hirvonen A, deWaziers I, Cabelguenne A, Mitrunen K, Cenee S et al (2002) Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility. Carcinogenesis 23:1475–1481. doi:10.1093/carcin/23.9.1475

    Article  PubMed  Google Scholar 

  37. Harris MJ, Coggan M, Langton L, Wilson SR, Board PG (1998) Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics 8:27–31. doi:10.1097/00008571-199802000-00004

    Article  PubMed  CAS  Google Scholar 

  38. Jourenkova-Mironova N, Wikman H, Bouchardy C, Voho A, Dayer P, Benhamou S (1998) Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer. Pharmacogenetics 8:495–502. doi:10.1097/00008571-199812000-00006

    Article  PubMed  CAS  Google Scholar 

  39. Saarikoski T, Voho A, Reinikainen M, Antilla S, Karjalainen A, Malaveille C et al (1998) Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer 77:516–521. doi:10.1002/(SICI)1097-0215(19980812)77:4<516::AID-IJC7>3.0.CO;2-X

    Google Scholar 

  40. Sugimura H, Wakai K, Genka K, Nagura K, Igarashi H, Nagayama K et al (1998) Association of Ile462 Val (Exon 7) polymorphism of cytochrome P450 IA1 with lung cancer in the Asian population: further evidence from a case–control study in Okinawa. Cancer Epidemiol Biomarkers Prev 7:413–417

    PubMed  CAS  Google Scholar 

  41. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K (2000) Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 9:3–28

    PubMed  CAS  Google Scholar 

  42. Le Marchand L, Guo C, Benhamou S, Bouchardy C, Cascorbi I, Clapper ML et al (2001) Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer Causes Control 14:339–346. doi:10.1023/A:1023956201228

    Article  Google Scholar 

  43. London SJ, Yuan JM, Coetzee GA, Gao YT, Ross RK, Yu MC (2000) CYP1A1 I462V genetic polymorphism and lung cancer risk in a cohort of men in Shanghai, China. Cancer Epidemiol Biomarkers Prev 9:987–991

    PubMed  CAS  Google Scholar 

  44. Song N, Tan W, Xing D, Lin D (2001) CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case control study in China. Carcinogenesis 22:11–16. doi:10.1093/carcin/22.1.11

    Article  PubMed  CAS  Google Scholar 

  45. Sreeja L, Syamala V, Hariharan S, Madhavan J, Devan SC, Ankathil R (2005) Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population. J Hum Genet 50:618–627. doi:10.1007/s10038-005-0303-3

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors wish to thank Dr. Ashwani Kumar, (acting) Director, IITR (CSIR, New Delhi), for continuous support. The financial assistance from ICMR (Delhi) to Munish Kumar is also acknowledged.

Author information

Authors and Affiliations

  1. Petroleum Toxicology Division, Indian Institute of Toxicology Research, M.G. Marg, P.O. Box No. #80, Lucknow, 226001, India

    Munish Kumar & Sudhir K. Goel

  2. Department of Biochemistry, Lucknow University, Lucknow, India

    Munish Kumar & Sudhir K. Agarwal

Authors
  1. Munish Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sudhir K. Agarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sudhir K. Goel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sudhir K. Goel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kumar, M., Agarwal, S.K. & Goel, S.K. Lung cancer risk in north Indian population: role of genetic polymorphisms and smoking. Mol Cell Biochem 322, 73–79 (2009). https://doi.org/10.1007/s11010-008-9941-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-008-9941-z

Keywords

Search

Navigation